Abstract Body

Background

HIV pre-exposure prophylaxis (PrEP) uptake remains disproportionately low among communities with the highest HIV incidence in the US due to stigma, structural inequities, limited access, and long wait times. Pharmacy-initiated PrEP could dramatically expand access, but pharmacy capacity for PrEP delivery has been understudied. Current legislation allows pharmacy-initiated PrEP in 10 states (including California) but has not yet been legalized in Maryland. Our objective was to assess the capacity of pharmacies in Baltimore and San Diego for initiating clients on PrEP.

Methods

We conducted a census of all licensed pharmacies in Baltimore, Maryland and San Diego, California, and administered brief surveys via phone, assessing capacity for PrEP initiation and the status of any pharmacy-initiated PrEP programs in place. We then conducted semi-structured interviews with a subset of pharmacists to explore perceptions of pharmacy-initiated PrEP and contextual determinants of implementation success. Survey data were analyzed descriptively; interview data were analyzed using qualitative content analysis and the Consolidated Framework for Implementation Research (CFIR).

Results

We contacted 418 pharmacies; 256 (61%) completed the survey. Chain pharmacies were the most predominant in Baltimore (41%) and San Diego (63.5%), followed by independent community pharmacies (33.5%; 19.3%). Most pharmacies could offer HIV-related counselling services (81%), with around 58% having a private space available for counselling. Ten pharmacies (5.5%) reported offering pharmacy-initiated PrEP in San Diego, with an average of 4 clients initiated per pharmacy. Limited ability to conduct point-of care testing for HIV, STIs, and liver function was observed. Interviews revealed substantial enthusiasm among pharmacists, with respondents feeling the program would reduce stigma and foster closer patient relations. However, barriers such as lack of awareness, prescribing status, staffing shortages, and insufficient financial compensation were highlighted. Pharmacists identified adequate training, advertisement to clients, and systems integration as essential for offering PrEP initiation. They also emphasized the need for proper workflow and protocols, reimbursement channels, and leadership support.

 

Conclusions

Adoption of pharmacy-initiated PrEP by pharmacies may improve PrEP accessibility, though additional implementation supports will be critical to expand the number and size of pharmacy-based PrEP programs.